Schmertzler Michael's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Aug 21, 2026
- Accession no.
- 0001288952-26-000004
- Filed
- Aug 21, 2026, 5:20 PM ET
- Trade date
- Aug 19-20, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.81M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schmertzler MichaelCIK 0001288952 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Common Stock | SSaleDisposed | −5,335 | $72.86 | −$388,708.1 | 1,381,259 | Indirect | |
| Aug 19, 2026 | Common Stock | SSaleDisposed | −7,165 | $73.67 | −$527,845.55 | 1,374,094 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −9,419 | $70.78 | −$666,676.82 | 1,364,675 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −2,390 | $71.88 | −$171,793.2 | 1,362,285 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −691 | $72.92 | −$50,387.72 | 1,361,594 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.